Diazepam Binding Inhibitor Antikörper (AA 2-105) (FITC)
Kurzübersicht für Diazepam Binding Inhibitor Antikörper (AA 2-105) (FITC) (ABIN7143222)
Target
Alle Diazepam Binding Inhibitor (DBI) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 2-105
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Acyl-CoA-binding protein (2-105AA)
-
Isotyp
- IgG
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Diazepam Binding Inhibitor (DBI)
-
Andere Bezeichnung
- DBI
-
Hintergrund
-
Background: Binds medium- and long-chain acyl-CoA esters with very high affinity and may function as an intracellular carrier of acyl-CoA esters. It is also able to displace diazepam from the benzodiazepine (BZD) recognition site located on the GABA type A receptor. It is therefore possible that this protein also acts as a neuropeptide to modulate the action of the GABA receptor.
Aliases: ACBD 1 antibody, ACBD1 antibody, ACBP antibody, ACBP_HUMAN antibody, Acyl CoA binding domain containing 1 antibody, Acyl CoA binding protein antibody, Acyl Coenzyme A binding domain containing 1 antibody, Acyl coenzyme A binding protein antibody, Acyl-CoA-binding protein antibody, CCK RP antibody, CCKRP antibody, Cholecystokinin releasing peptide trypsin sensitive antibody, DBI antibody, Diazepam-binding inhibitor antibody, Endozepine antibody, EP antibody, GABA receptor modulator antibody, MGC70414 antibody
-
UniProt
- P07108
Target
-